Contracting Restrictions
THE ISSUE: Most medical device companies and sales reps earn an income by selling new devices to hospitals. AMDR member reprocessors are aligned with healthcare partners by seeking to extend the value of existing medical
Forced Obsolescence Designed Into Devices
THE ISSUE: Billed as “innovation,” some medical device manufacturers introduce new models of existing technology that are designed to make it impossible to reprocesses and reuse them. When such generational innovation disallows reprocessing, the hospital
Software “Updates” Aimed to Thwart Reprocessing
THE ISSUE: Many electrosurgical instruments and cardiology catheters have been cleared by FDA or certified by Notified Bodies for reprocessing. These are expensive devices that range from hundreds to thousands of dollars each with several
Blended Pricing and Product Mixes
THE ISSUE: A vendor may offer hospitals a mix of new and reprocessed devices at a blended price, or for a price lower than buying all new -- but slightly higher than for buying all
Refusal to Provide Technical Support
THE ISSUE: AMDR has received repeated reports that sales reps from a major cardiac catheter manufacturer have threatened to remove hospital tech support in cases where third-party reprocessed catheters are being used. The alleged reason
AMDR President, Dan Vukelich, will meet with the Japanese SUD Remanufacturing Association (JRSA) in Tokyo for a roundtable event June 27
AMDR President, Dan Vukelich, will meet with the Japanese SUD Remanufacturing Association (JRSA) in Tokyo for a roundtable event June 27. This intra-industry event is dedicating to introducing AMDR member reprocessors to JRSA members, discussing respective agendas and